VAXCYTE, INC. Prepaid Expense, Noncurrent
VAXCYTE, INC. (PCVX) had Prepaid Expense, Noncurrent of $284.00 thousand as of 2024-09-30, per its 10-Q filed 2024-11-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:PrepaidExpenseNoncurrent · last filed 2024-11-05
- 2024-09-30: Prepaid Expense, Noncurrent $284.00K.
- 2024-06-30: Prepaid Expense, Noncurrent $55.00K.
- 2024-03-31: Prepaid Expense, Noncurrent $2.47M.
- 2023-12-31: Prepaid Expense, Noncurrent $106.00K; Prepaid Expense, Noncurrent as first filed $2.77M.
| Period end | Prepaid Expense, Noncurrent | Prepaid Expense, Noncurrent as first filed |
|---|---|---|
| 2024-09-30 | $284.00K 10-Q · filed 2024-11-05 | |
| 2024-06-30 | $55.00K 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $2.47M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $106.00K 10-Q · filed 2024-11-05 | $2.77M 10-K · filed 2024-02-27 |
| 2022-12-31 | $4.36M 10-K · filed 2024-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |